Strategies To Overcome and Prevent (STOP) Obesity Alliance
Driving innovative & Practical strategies to combat obesity
The Strategies to Overcome and Prevent (STOP) Obesity Alliance comprises a diverse group of individual, government, advocacy, business, and health organizations dedicated to reversing the obesity epidemic in the United States. Drawing on the strengths of the collaborative, the Alliance conducts research, makes policy recommendations, and develops hands-on tools for providers, advocates, consumers, and policymakers.
What we do to STOP obesity
Conduct Research
Analyze and publish data related to coverage and the costs of obesity, including direct medical and employer-borne costs, but also those related to stigma and bias that impact quality of care.
Develop Tools
Develop research-based patient and health care provider guides to facilitate respectful, productive conversations around weight. Generate reports and guidance that provide essential obesity-related information for policymakers, legislators, and other decision-makers.
Drive Collaboration
Convene key experts for meetings and roundtables to explore and address specific focus areas and barriers to obesity prevention, care, treatment, and coverage, and execute on identified needs.
Sign up for our monthly Newsletter
Subscribe below to receive STOP's monthly email. Each month it is packed with insights from experts in obesity prevention and treatment, details on upcoming events, and exciting news from our member organizations!
Resources
Recent Letters from our Director, Dr. William H. Dietz
Obesity Care Week 2026
February 27, 2026
Obesity Care Week (OCW) brings together advocates and organizations nationwide to raise awareness, educate, and advocate for people affected by obesity.
The New Dietary Guidelines for Americans, 2025-2030
January 30, 2026
Earlier this month, the US Department of Health and Human Services (HHS) and the US Department of Agriculture (USDA) released the 2025-2030 Dietary Guidelines for Americans (DGAs).
Guest Letter: A Path Forward: What’s Possible for Obesity Care in 2026
January 1, 2026
Last month, the administration delivered another critical victory: a landmark Medicare and Medicaid price negotiation deal for the GLP-1 medications Wegovy and Zepbound.